Moving Biotech gets Health Canada approval to initiate phase 2a INFLAM MOTION clinical trial for knee osteoarthritis: Lille & Paris, France Saturday, March 29, 2025, 17:00 Hrs [I ...
DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community: Jena, Germany Saturday, March 29, 202 ...
Seoul, South Korea Saturday, March 29, 2025, 14:00 Hrs [IST] ...
Abbott Park, Illinois Saturday, March 29, 2025, 13:00 Hrs [IST] ...
CDSCO declares a total of 103 drug samples as NSQ in February: Our Bureau, New Delhi Saturday, March 29, 2025, 13:30 Hrs [IST] The Central Drugs Standard Control Organisation (CDS ...
NPPA revises ceiling prices of scheduled drugs as per increase in annual WPI: Our Bureau, New Delhi Saturday, March 29, 2025, ...
Bayer, Puhe BioPharma ink global license pact to develop, manufacture and commercialize the MTA-cooperative PRMT5 inhibitor: Berlin, Germany Saturday, March 29, 2025, 12:00 Hrs [I ...
Merck’s pembrolizumab with berahyaluronidase alfa demonstrates noninferior PK compared to IV Keytruda in pivotal 3475A-D77 trial: Rahway, New Jersey Saturday, March 29, 2025, 10 ...
Chugai Pharma’s Evrysdi tablets 5mg receives Japanese approval to treat spinal muscular atrophy: Saturday, March 29, 2025, 11:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd. announ ...
Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...
Nandita Vijayasimha, Bengaluru Saturday, March 29, 2025, 08:00 Hrs [IST] ...
Anti-dumping investigation initiated on imports of EDA from China, EU, Saudi Arabia & Taiwan: Shardul Nautiyal, Mumbai Saturday, March 29, 2025, 08:00 Hrs [IST] The Directorate Ge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback